|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
Neurofibromatosis Type 2
by Pamela Jones, MA
Neurofibromatosis is a genetic disorder that causes tumors in the nervous system. Tumors develop in the nerves or the tissue that surrounds the nerves, called the myelin sheath. Neurofibromatosis is divided into 3 types, neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. The type is determined by the specific genes that are affected.
This article discusses NF2. These tumors tend to arise in the central nervous system. The eighth cranial nerve, which affects hearing and balance, is the most commonly involved nerve.
NF is caused by a change in a specific gene. The gene normally makes proteins that help control growth in the nerves. Since the gene is defective, these proteins are not able to control growth, and tumors develop.
In many cases, the abnormal gene is inherited from a parent. A person with the inherited form of NF has a 50% chance of passing the abnormal gene to each child. Any parents, children, and siblings of an affected individual should be considered at risk for NF. However, the gene change can occur in a person with no family history of NF.
Risk Factors TOP
The main risk factor for NF is having a family member with the disease.
Symptoms will depend on the exact location and size of the tumor. Smaller tumors may not cause symptoms.
Symptoms that may occur include:
You will be asked about your medical and family medical history. A physical exam will also be done. It may take a few years before NF2 is diagnosed. NF2 may be suspected if there is a presence or history of:
The diagnosis is generally made based on your history, symptoms, and the physical exam.
An MRI scan may be done to create images of the nerves and brain to look for tumors. Samples of tumors may also be removed and sent for microscopic evaluation.
There are no current treatments to stop these tumors from growing. Treatment may not be needed since these tumors are rarely cancerous, grow slowly, and may not cause problems. You will be referred to a specialist for regular check-ups. Regular exams are recommended to check for new tumors or symptoms.
Surgery may be needed to remove tumors that are causing symptoms such as hearing loss. Other surgeries may be needed, such as cochlear implants or cataract repairs.
Some tumors may also shrink in response to radiation or certain medication. These treatments can have some side effects and complications. You and your doctor will weigh the risks and benefits of each treatment option.
There are no guidelines for preventing neurofibromatosis.
Genetic testing may be recommended for families with a history of neurofibromatosis. Prenatal diagnosis may also be possible with amniocentesis or chorionic villus sampling.
Children's Tumor Foundation
Brain Tumour Foundation of Canada
The Tumour Foundation of BC
Intro to NF. Children's Tumor Foundation website. Available at:
...(Click grey area to select URL)
Accessed November 28, 2017.
Neurofibromatosis type 2. EBSCO DynaMed Plus website. Available at: http://www.dynamed.... Updated February 8, 2016. Accessed November 28, 2017.
NINDS neurofibromatosis information page. National Institute of Neurological Disorders and Stroke website. Available at: https://www.ninds.nih.gov/Disorders/All-Disorders/Neurofibromatosis-Information-Page. Accessed November 28, 2017.
Last reviewed November 2017 by EBSCO Medical Review Board James Cornell, MD
Last Updated: 12/20/2014
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.